Navigation Links
Huifeng Bio-Pharmaceutical Technology Announces New Senior Vice President of Finance
Date:3/23/2011

XI'AN, China, March 23, 2011 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB) ("Huifeng" or "the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced the appointment of Ms. Amy Xue to Senior Vice President of Finance.

"We are truly delighted that Ms. Xue will be a part of the Company," said Jing'an Wang, Founder, Chairman, and Chief Executive Officer of Huifeng. "Her appointment is an important step in strengthening the Company's internal controls over financial reporting. Ms. Xue brings a tremendous amount of knowledge and strategic counsel to our senior management team and we are fully confident that she will play an integral role in the achievement of Huifeng's growth and financial goals."

Ms. Xue has extensive experience in U.S. GAAP financial reporting and public accounting, and she has performed audit and accounting services for companies in a variety of industries. In 2010, she founded Farolfi & Company, LLC, a New York based accounting and business advisory firm. Prior to that, Ms. Xue was a senior manager of Acquavella, Chiarelli, Shuster, Berkower & Co., LLP, a public accounting firm in New York that focuses on SEC audits with Chinese companies.

Ms. Xue holds a Master's in accounting from Binghamton University and a B.S. in law from Peking University in Beijing, China. She is a U.S. Certified Public Accountant in New York and a member of the American Institute of Certified Public Accountants (AICPA).

About Huifeng Bio-Pharmaceutical Technology, Inc.Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. More information can be found on the Company's web site at: http://www.hfgb.cn/

Safe Harbor StatementThis release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors.Investor Contact:Mr. Kevin FickleNUWA Group, LLCTel: +1-925-330-8315Email: Kevin@nuwagroup.comCompany Contact:Ms. Bing HeHuifeng Bio-Pharmaceutical Technology, Inc.Tel: +86-139-9195-4170Email: ir@xahuifeng.com
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
2. Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order
3. Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
4. Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract
5. Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat
6. Technology Embracing Pharmacy, Millennium Pharmacy Systems, Welcomes New CIO
7. CardioMEMS, Inc. Named a TAG Top 10 Innovative Technology Company
8. Alzheimers Drug Discovery Foundation Supports ADispell Technology with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
9. Saffron Technology Adds Seasoned Business Executives to Advisory Board
10. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
11. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
(Date:4/27/2016)... 2016 Global  urinalysis market ... by 2022, according to a new report by ... http://photos.prnewswire.com/prnh/20150105/723757 ) , Automation ... and accuracy delivered by the new generation urinalysis ... urinalysis instruments and consumables. For instance, the automatic ...
(Date:4/26/2016)... April 26, 2016 Diplomat Pharmacy, Inc. (NYSE: ... Jennifer Hagerman , Pharm D., to Vice President of ... at Diplomat, Hagerman will continue to lead and oversee ... delivers custom education and training to Diplomat employees and ... industry. Diplomat University also houses the quality assurance department, ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... A new study by a ... diaphragmatic hernia have better survival rates if surgery is performed early. Approximately one ... the diaphragm fails to form completely, letting abdominal organs into the chest cavity ...
(Date:4/29/2016)... ... 29, 2016 , ... The Wharton School of the ... Prize of the 2016 Wharton Business Plan Competition —as well as the ... and the Committee Award for Most ‘Wow Factor,’ making them the first team ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 percent ... cancer deaths. More than 10,000 people are expected to die of melanoma this year. The ... the one of the most commonly diagnosed cancers in young women. A recent breakthrough in ...
(Date:4/29/2016)... ... ... City based oral and maxillofacial surgeon Dr. Majid Jamali is an expert in ... apnea. Dr. Jamali is proud to offer this permanent solution to patients who suffer from ... bones. This surgery is performed to correct the alignment of the jaw. It is beneficial ...
Breaking Medicine News(10 mins):